SignatureFD’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $101K | Buy |
3,417
+1,565
| +85% | +$44.8K | ﹤0.01% | 1539 |
|
|
2026
Q2 | $55.5K | Buy |
1,852
+241
| +15% | +$6.84K | ﹤0.01% | 1807 |
|
|
2026
Q1 | $48.3K | Sell |
1,611
-30
| -2% | -$993 | ﹤0.01% | 1742 |
|
|
2025
Q4 | $53.7K | Sell |
1,641
-199
| -11% | -$6.42K | ﹤0.01% | 1607 |
|
|
2025
Q3 | $63.7K | Buy |
1,840
+275
| +18% | +$8.8K | ﹤0.01% | 1508 |
|
|
2025
Q2 | $43.8K | Sell |
1,565
-299
| -16% | -$8.02K | ﹤0.01% | 1654 |
|
|
2025
Q1 | $46.8K | Sell |
1,864
-4,972
| -73% | -$126K | ﹤0.01% | 1605 |
|
|
2024
Q4 | $188K | Buy |
6,836
+423
| +7% | +$11.8K | ﹤0.01% | 902 |
|
|
2024
Q3 | $185K | Buy |
6,413
+2,541
| +66% | +$69.2K | ﹤0.01% | 907 |
|
|
2024
Q2 | $95.9K | Buy |
3,872
+1,258
| +48% | +$35.7K | ﹤0.01% | 1179 |
|
|
2024
Q1 | $84.2K | Buy |
2,614
+644
| +33% | +$23.9K | ﹤0.01% | 1279 |
|
|
2023
Q4 | $80.1K | Buy |
1,970
+867
| +79% | +$31.9K | ﹤0.01% | 1229 |
|
|
2023
Q3 | $38.1K | Buy |
1,103
+195
| +21% | +$7.59K | ﹤0.01% | 1527 |
|
|
2023
Q2 | $36.9K | Buy |
908
+279
| +44% | +$11.4K | ﹤0.01% | 1583 |
|
|
2023
Q1 | $24.3K | Buy |
629
+308
| +96% | +$12.7K | ﹤0.01% | 1761 |
|
|
2022
Q4 | $14.2K | Buy |
321
+282
| +723% | +$11.9K | ﹤0.01% | 1964 |
|
|
2022
Q3 | $2K | Sell |
39
-370
| -90% | -$19K | ﹤0.01% | 2775 |
|
|
2022
Q2 | $23K | Sell |
409
-80
| -16% | -$4.74K | ﹤0.01% | 1692 |
|
|
2022
Q1 | $30K | Sell |
489
-16
| -3% | -$979 | ﹤0.01% | 1632 |
|
|
2021
Q4 | $28K | Buy |
505
+264
| +110% | +$13.8K | ﹤0.01% | 1620 |
|
|
2021
Q3 | $13K | Buy |
241
+7
| +3% | +$416 | ﹤0.01% | 1939 |
|
|
2021
Q2 | $16K | Buy |
234
+183
| +359% | +$14K | ﹤0.01% | 1803 |
|
|
2021
Q1 | $4K | Buy |
51
+2
| +4% | +$184 | ﹤0.01% | 2234 |
|
|
2020
Q4 | $5K | Buy |
49
+12
| +32% | +$1.47K | ﹤0.01% | 1952 |
|
|
2020
Q3 | $5K | Buy |
37
+15
| +68% | +$2.5K | ﹤0.01% | 1892 |
|
|
2020
Q2 | $4K | Sell |
22
-19
| -46% | -$3.94K | ﹤0.01% | 1882 |
|
|
2020
Q1 | $8K | Buy |
41
+3
| +8% | +$645 | ﹤0.01% | 1543 |
|
|
2019
Q4 | $8K | Buy |
38
+34
| +850% | +$6.28K | ﹤0.01% | 1516 |
|
|
2019
Q3 | $1K | Buy |
+4
| New | +$655 | ﹤0.01% | 1946 |
|
Other funds holding LKFT
SignatureFD's LKFT Position: Q3 2026 in Review
SignatureFD increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 85% in Q3 2026, buying an estimated $44.8K and bringing the position to 3,417 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #1539.
SignatureFD first reported a position in LKFT in Q3 2019 and has held it in 29 quarters since. The position peaked at $188K in Q4 2024. 8 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.
- SignatureFD held 3,417 shares of Lakefront Biotherapeutics American Depositary Shares worth $101K as of Q3 2026.
- SignatureFD bought 1,565 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $44.8K.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1539 holding.
- SignatureFD first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2019 and has held it in 29 quarters since.
- SignatureFD's Lakefront Biotherapeutics American Depositary Shares position peaked at $188K in Q4 2024.
- 8 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.
Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.